Ormat Technologies Inc. (NYSE:ORA) shares decreased -1.76% in last trading session and ended the day at $40.83. ORA Gross Margin is 36.70% and its has a return on assets of 5.30%. Ormat Technologies Inc. (NYSE:ORA) quarterly performance is 11.17%.
Ormat Technologies, Inc. (NYSE:ORA) is pleased to announce that its 2016 annual meeting of stockholders will be held on Wednesday, May 4, 2016 at 1:30 p.m. EDT at the offices of Chadbourne & Parke LLP, 1301 Avenue of the Americas, New York, NY 10019-6022. Stockholders of record on the close of business on March 16, 2016 will be entitled to notice of, and to vote at, the meeting.
DENTSPLY SIRONA Inc. (NASDAQ:XRAY) ended the last trading day at $62.06. Company weekly volatility is calculated as 2.04% and price to cash ratio as 52.72. DENTSPLY SIRONA Inc. (NASDAQ:XRAY) showed a weekly performance of 1.89%.
DENTSPLY SIRONA Inc. (NASDAQ:XRAY) announced that its Board of Directors declared a quarterly cash dividend of $0.0775 per share of common stock, an indicated annual rate of $0.31 per share. This represents an increase of 7% from the prior annual rate of $0.29 per share. The dividend is payable on April 8, 2016 to holders of record on March 25, 2016.
On 30 March, A. Schulman, Inc. (NASDAQ:SHLM) shares decreased -0.30% and was closed at $26.50. SHLM EPS growth in last 5 year was -13.50%. A. Schulman, Inc. (NASDAQ:SHLM) year to date (YTD) performance is -12.79%.
A. Schulman (NASDAQ: SHLM) declared a quarterly dividend of $0.205 per share, or $0.82 annualized. The dividend will be payable on May 2, 2016, to stockholders of record on April 15, 2016, with an ex-dividend date of April 13, 2016.
Compugen Ltd. (NASDAQ:CGEN) shares advanced 1.79% in last trading session and ended the day at $5.69. CGEN Gross Margin is 82.80% and its has a return on assets of -19.70%. Compugen Ltd. (NASDAQ:CGEN) quarterly performance is -12.06%.
Compugen Ltd. (NASDAQ: CGEN), a leading predictive drug discovery company, announced that Anat Cohen-Dayag, Ph.D., President and Chief Executive Officer of Compugen, will present an overview of the Company’s immuno-oncology programs and underlying predictive discovery capabilities at the Jefferies 2016 Immuno-Oncology Summit in Boston, on Thursday, April 7, 2016.
Vale S.A. (NYSE:VALE) caters to the Basic Materials space. It has a net profit margin of -48.70% and weekly performance is 0.24%. On the last day of trading company shares ended up at $4.24. Vale S.A. (NYSE:VALE) distance from 50-day simple moving average (SMA50) is 35.07%.
Former Vale SA (NYSE:VALE) mining CEO Roger Agnelli was killed in a plane crash in Brazil, March 19. Reuters reported Agnelli, 56, his wife and two children were among seven killed when his turboprop monoplane slammed into two homes around 3:20 p.m. local time, minutes after taking off from an airport in northern São Paulo.
Leave a Reply